ESC 365 - Antithrombotic treatment in patients with stable CAD and AF - 5-year follow-up data from the CLARIFY registry

Back

ESC Premium Access

Antithrombotic treatment in patients with stable CAD and AF - 5-year follow-up data from the CLARIFY registry

Session: Antithrombotic strategies in coronary artery disease

Topic: Thrombosis and coagulation

Speaker: Professor R. Wakili (Frankfurt, DE)

Event: ESC Congress 2017

Congress Presentation

Add to my library

About the speaker

Professor Reza Wakili

J. W. Goethe University Frankfurt, Frankfurt (Germany)

9 presentations

1 follower

9 more presentations in this session

Application of DAPT score to predict ischaemic and bleeding events in patients who underwent drug-eluting stent implantation: a landmark analysis of large pooled cohort

Speaker: Doctor Y. Yoshikawa (Kyoto, JP)

Growth differentiation factor 15 and bleeding risk with ticagrelor in patients with prior myocardial infarction: insights from PEGASUS-TIMI 54.

Speaker: Doctor M. Bonaca (Aurora, US)

In-hospital switch of P2Y12 drugs in patients presenting with acute coronary syndrome: a meta-analysis of 14 observational and randomized studies including 10961 patients.

Speaker: Doctor M. Bianco (Orbassano, IT)

Optimal long-term antithrombotic treatment of patients with stable coronary artery disease and atrial fibrillation: OLTAT registry

Speaker: Doctor Q. Fischer (Paris, FR)

The effect of CYP2C19 gene polymorphism and clopidogrel dose on clinical outcomes in Asian populations with CAD receiving antiplatelet therapy.

Speaker: Mr W. Liu (Beijing, CN)

Access the full session

Antithrombotic strategies in coronary artery disease

Speakers: Professor R. Wakili, Doctor Y. Yoshikawa, Doctor M. Bonaca, Doctor M. Bianco, Doctor Q. Fischer...

Access

About the event

ESC Congress 2017

26 August - 30 August 2017

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources